COVID-19 FUNDING OPPORTUNITIES

COVID-19 NIH grant editing, COVID-19 research proposal assistance

image55


PA-20-135
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)

PA-18-935
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement -  Clinical Trial Optional)

Notice Number: NOT-GM-20-025
Notice  of Special Interest (NOSI) regarding the Availability of Urgent  Competitive Revisions for Research on Coronavirus Disease 2019  (COVID-19) and the Causative Virus SARS-CoV-2

Notice Number: NOT-AI-20-040
Notice of Early Expiration of NOT-AI-20-030; informs the extramural community that NOT-AI-20-030,  “Notice of Special Interest (NOSI) regarding Availability of Urgent  Competitive Revisions for Research on the 2019 Novel Coronavirus  (2019-nCoV)” will be rescinded as of 04/08/2020 & replaced by NOT-AI-20-034 for NIAID competitive revisions and NOT-GM-20-025 for NIGMS competitive revisions.

NIAID will replace NOT-AI-20-030 with NOT-AI-20-034 which uses a different funding opportunity announcement, PA-20-135,  “Emergency Competitive Revision to Existing NIH Awards (Clinical Trial  Optional)” for competitive revision application submissions in response  to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and  Coronavirus Disease 2019 (COVID-19) outbreak. NIAID applicants will have  the option of applying to either NOT-AI-20-030 or NOT-AI-20-034 only until 04/08/2020, and are strongly encouraged to transition their application to NOT-AI-20-034 using the PA-20-135,  “Emergency Competitive Revision to Existing NIH Awards (Clinical Trial  Optional)”. NIGMS will issue a new NOSI that will continue to use PA-18-935.


Get the latest public health information from CDC


Get the latest research information from NIH